TMRW Life Sciences, known for its automation technology in IVF labs, has announced its expansion into the United Kingdom. This strategic move introduces the company’s advanced CryoRobot Select (CRS) system to the UK market, starting with The Hewitt Fertility Centre in Liverpool. The CRS system automates the storage and management of frozen eggs and embryos, aiming to enhance safety and efficiency in fertility treatments.
The UK’s recent policy changes, extending the storage limit for frozen reproductive materials, have amplified the demand for more reliable and efficient storage solutions. TMRW’s technology addresses this need by reducing human error through automation. The CRS system, equipped with RFID technology, significantly reduces the risks associated with manual storage methods.
“I am delighted for Hewitt Fertility patients and for the scientific team that we can finally announce the introduction of TMRW’s CRS into our clinical pathways” said Dr. Rachel Gregoire, Scientific Director/HFEA Person Responsible for The Hewitt Fertility Centres. “It is a credit to Rebecca, Lead Clinical Embryologist and the team who have worked tirelessly with the incredible people at TMRW to make this happen. Almost three years ago, Hewitt demonstrated that manual cryostorage involves potential unnecessary handling events of patient samples in storage, and Hewitt is so pleased to be the first fertility clinic outside of the USA to offer TMRW’s innovative CE Marked technology for our patients. We all wish to thank Liverpool Women’s NHS Foundation Trust for listening to us and for investing in this technology so that the Hewitt Fertility Centres can continue to be leaders in offering safe and innovative fertility treatments.”
“Our partnership with The Hewitt Fertility Centre represents the first step in our global expansion and illustrates our commitment to raising the global standard of care,” said Louis Villalba, Chief Executive Officer at TMRW. “We applaud The Hewitt Fertility Centre for being the first IVF clinic outside of the United States to adopt our CE Marked and FDA Cleared specimen management system. Our collaboration heralds a new era of safety and precision in managing frozen eggs and embryos in the UK.”
As TMRW extends its reach to the UK, the move signifies a broader trend of incorporating more sophisticated technology in healthcare. This development is expected to influence the wider adoption of similar technologies in fertility clinics across Europe and globally.
